Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing Read more about Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing Read more about Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
First Cancer Trial Launched Using CAR T Cells Engineered with Bellicum’s Safety Switch Read more about First Cancer Trial Launched Using CAR T Cells Engineered with Bellicum’s Safety Switch
Bellicum Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference In New York City Read more about Bellicum Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference In New York City
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology Read more about ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology
Jim Daly Member of the Nominating and Governance CommitteeMember of the Compensation Committee Jim Daly
Reid Huber Chair of the Nominating and Governance CommitteeMember of the Audit Committee Reid M. Huber, PhD